ACETO Corp (ACET) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
ACETO Reports Fiscal 2018 First Quarter Results
November 2, 2017 5:00 PM EDTPORT WASHINGTON, N.Y., Nov. 02, 2017 (GLOBE NEWSWIRE) -- ACETO Corporation (Nasdaq: ACET), focused on the global marketing, sale and distribution of Human Health products, Pharmaceutical Ingredients and Performance Chemicals, announced today financial results for the first quarter of fiscal 2018 ended September 30, 2017.
First Quarter Fiscal 2018 versus First Quarter Fiscal 2017
Net sales of $185.3 million versus $128.0 million, a 44.7% increaseGross profit of $40.0 million versus $30.8 million, a 29.7% increaseNet income of $0.5 million versus $4.4 million, a 89.6% decreaseDiluted EPS of $0.01 versus $0.15, an 93.3% decreaseNon-GAAP Adjusted Net Income of $10.7 million versus $8.3 million, a... More


